Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phabril was a German pharmaceutical company headquartered in Waltrop that specialized in the parallel import and distribution of brand-name medications. The company's business model centered on sourcing pharmaceuticals from EU countries with lower price levels and distributing them to pharmacies and wholesalers in Germany. Phabril ensured compliance with strict regulatory standards through specialized repackaging and labeling processes. The company offered a wide range of therapeutic products, including treatments for oncology, cardiovascular diseases, and neurology. It was eventually integrated into the EurimPharm group, a major player in the European parallel import market. Following the merger, its operations were consolidated to streamline the supply chain for imported medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phabril Waltrop.